Leef Brands (LEEEF) Prepaid Assets (2024 - 2026)

Leef Brands (LEEEF) posted Prepaid Assets of $1.3 million for Q1 2026, up 149.25% sequentially from $505438.0 in Q4 2025.

Leef Brands (LEEEF) Prepaid Assets (2024 - 2026) Analysis & Trends

Leef Brands has reported Prepaid Assets for 3 years, with the latest figure at $1.3 million in Q1 2026.

Quarterly Prepaid Assets changed N/A year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $505438.0, down 18.68% from the prior year.
Prepaid Assets rose to $1.3 million in Q1 2026 per LEEEF's latest filing, from $505438.0 in the prior quarter.
Over five years, Prepaid Assets peaked at $1.3 million in Q1 2026 and troughed at $505438.0 in Q4 2025.
A 3-year average of $795590.3 and a median of $621527.0 in 2024 frame the typical range for Prepaid Assets.
The widest YoY moves for Prepaid Assets: up 18.68% in 2025, down 18.68% in 2025.
Over 3 years, Prepaid Assets stood at $621527.0 in 2024, then decreased by 18.68% to $505438.0 in 2025, then soared by 149.25% to $1.3 million in 2026.
According to Business Quant data, Prepaid Assets over the past three periods registered $1.3 million, $505438.0, and $621527.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Leef Brands	58.70 Mn	53.75 Mn	2.41 Mn

Download Data